Cerebral toxoplasmosis is a brain infection caused by the parasite Toxoplasma gondii that predominantly affects those with weakened immune systems, especially those living with HIV/AIDS. The parasite exists in three forms that can infect humans. Risk factors include older age, male gender, low CD4 cell count, and high HIV viral load. Cerebral toxoplasmosis can have high mortality and morbidity rates if left untreated.
Cerebral toxoplasmosis is a brain infection caused by the parasite Toxoplasma gondii that predominantly affects those with weakened immune systems, especially those living with HIV/AIDS. The parasite exists in three forms that can infect humans. Risk factors include older age, male gender, low CD4 cell count, and high HIV viral load. Cerebral toxoplasmosis can have high mortality and morbidity rates if left untreated.
Cerebral toxoplasmosis is a brain infection caused by the parasite Toxoplasma gondii that predominantly affects those with weakened immune systems, especially those living with HIV/AIDS. The parasite exists in three forms that can infect humans. Risk factors include older age, male gender, low CD4 cell count, and high HIV viral load. Cerebral toxoplasmosis can have high mortality and morbidity rates if left untreated.
Definition • Cerebral toxoplasmosis is an infection of T. gondii that affects the brain with high mortality and morbidity rates, especially in low-to middle-income countries and tropical regions, including Indonesia. • Cerebral toxoplasmosis is an opportunistic infection that is often found in people living with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) known as PLWHA. Etiology • Toxoplasma Gondii • Toxoplasma Gondii merupakan parasit obligat intraseluler • T. gondii progresses through 3 main distinctive forms, namely, oocyst (containing sporozoites), tachyzoite, and tissue cyst (containing bradyzoites). Risk Factor • Age • Gender • Low CD4 cell count • High HIV viral load Reference • Berlianty B, Sofianti D, Ahmad RG. Glasgow Outcome Scale Assessment in Patients with Cerebral Toxoplasmosis. Althea Medical Journal. 2022;9(1):30–36 • Yostila D, Armen A. Toxoplasmosis Cerebri Pada HIV AIDS. Jurnal Kesehatan Andalas. 2018; 7(Supplement 4) • Elsheikha HM. Christina M, Xing-Quan Z. Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis. PubMed. Cited [19 Mei 2022]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690944/ • I Maed Dwinata. Putu Eka W. Putri Rossyana D. Eric Hartono T. Risk factors of cerebral toxoplasmosis in HIV patients : A systematic review. 2021. Romanian Journal of Neurology.